CoChat

Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

Newcomer, John W., Sernyak, Michael J. · 2007 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

Mental health providers have an especially important responsibility to monitor the physical changes that patients have in response to medication. The current public health focus is on adiposity as a major risk factor for diabetes, coronary heart disease, insulin resistance syndrome, metabolic syndrome, and other diseases. Adiposity has an adverse effect on insulin action, which can lead to a cycle in which insulin loses its ability to stop the breakdown of fat. Because type 2 diabetes takes approximately 2 decades to develop, patients with increased BMI can be at risk for adverse effects to their physical health for many years. Because of the possibility that some antipsychotic treatments can lead to weight gain and metabolic changes and possibly to severe physical illness, regular physical checks should be made.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.0707e17

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 93

Metadata

Authors
Newcomer, J. W., & Sernyak, M. J.
Affiliations
Washington University in St. Louis (US)
Venue
The Journal of Clinical Psychiatry
Published
2007-07-15
Volume
68
Issue
07
Pages
e17
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2991752231
Cited by
93
References
0
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 1 · 2014: 9 · 2013: 4 · 2012: 3
FWCI
2.81
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
antipsychotic drugs, metabolic risk, weight gain, adiposity, type 2 diabetes, insulin resistance, metabolic syndrome, coronary artery disease, body mass index, therapeutic drug monitoring, physical health screening
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Humans, Insulin Resistance, Antipsychotic Agents, Weight Gain, Body Mass Index, Metabolic Syndrome, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies. https://app.cochat.ai/papers/10.4088/jcp.0707e17
The paper
Newcomer, J. W., & Sernyak, M. J. (2007). Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.0707e17

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.